Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10838063 | Pharmacology Biochemistry and Behavior | 2012 | 9 Pages |
Abstract
⺠Moderate NE loss reduces L-DOPA-induced dyskinesia and rotations. ⺠The α2-adrenergic antagonist idazoxan attenuates L-DOPA-induced dyskinesia. ⺠Propranolol, a b-adrenergic antagonist, reduces L-DOPA-induced dyskinesia. ⺠NE lesions do not alter anti-dyskinetic effects of adrenergic receptor antagonists.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Christopher J. Barnum, Nirmal Bhide, David Lindenbach, Margaret A. Surrena, Adam A. Goldenberg, Stefanie Tignor, Anna Klioueva, Hannah Walters, Christopher Bishop,